Protocatechuic acid alleviates chronic obstructive pulmonary disease model by reducing inflammation and oxidative stress via the AHR/CYP1A1/CYP1A2 pathway
General physiology and biophysics · 2025
DOI: 10.4149/gpb_2025013 ↗Kurz gefasst
Fachartikel in der Zeitschrift General physiology and biophysics, 2025. Verfasst von Xingyu Pan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Haining Second People's Hospital, Jiaxing, Zhejiang, China. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Oxidative Stress, Receptors, Aryl Hydrocarbon, Hydroxybenzoates. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Haining Second People's Hospital, Jiaxing, Zhejiang, China.
- Department of Respiratory Medicine, Haining Second People's Hospital, Jiaxing, Zhejiang, China.
- Director of Pharmacy Department, Haining Traditional Chinese Medicine Hospital, Jiaxing, Zhejiang, China.
- Safety Assessment Center, Hangzhou Medical College, Jiaxing, Zhejiang, China.
- Clinical Inspection Center, Haining Second People's Hospital, Jiaxing, Zhejiang, China.
ORCID-Profile: Yongjia Zhu
Zitieren
APA
Pan, X., Zhang, X., Li, R., Zhang, S., Zhang, C., & Zhu, Y. (2025). Protocatechuic acid alleviates chronic obstructive pulmonary disease model by reducing inflammation and oxidative stress via the AHR/CYP1A1/CYP1A2 pathway. General physiology and biophysics. https://doi.org/10.4149/gpb_2025013
Vancouver
Pan X, Zhang X, Li R, Zhang S, Zhang C, Zhu Y. Protocatechuic acid alleviates chronic obstructive pulmonary disease model by reducing inflammation and oxidative stress via the AHR/CYP1A1/CYP1A2 pathway. General physiology and biophysics. 2025. doi:10.4149/gpb_2025013
BibTeX
@article{Pan2025,
author = {Pan, Xingyu and Zhang, Xiaowei and Li, Ruizhi and Zhang, Sheng and Zhang, Chengda and Zhu, Yongjia},
title = {Protocatechuic acid alleviates chronic obstructive pulmonary disease model by reducing inflammation and oxidative stress via the AHR/CYP1A1/CYP1A2 pathway},
journal = {General physiology and biophysics},
year = {2025},
doi = {10.4149/gpb_2025013}
}
EUVIMED